NCT06003725 Cultural Adaptation of Drug Treatment for DJJ Youth
| NCT ID | NCT06003725 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Substance Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 55 participants |
| Start Date | 2024-05-15 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 55 participants in total. It began in 2024-05-15 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.
Eligibility Criteria
For Focus Groups and Interviews: Black JIY Participants: Inclusion Criteria: • 1) Between the ages of 13-17; 2) identify as Black or African American; and 3) on community probation. Exclusion Criteria: • Will be excluded if they do not have parental consent to participate. For Focus Groups and Interviews: Adult Participants Inclusion Criteria: * A guardian of JIY * An advocate (someone who supports change and reform in the justice community) for Black JIY. Exclusion Criteria: • Will be excluded if they do not provide consent to participate. For pilot feasibility study: Black JIY Participants: Inclusion Criteria: * Between the ages of 13 and 17 * Identify as Black or African American * Be on community probation * Meet criteria for alcohol, cannabis, or other drug misuse as defined by the DSM 5 * Be experiencing at least 1 problem related to AOD; * The frequency of AOD must be weekly use over a 3-month period Exclusion Criteria: * Will be excluded if they do not have parental consent to participate * Parole violation
Contact & Investigator
Brittany Bryant, DSW
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06003725 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 17 Years, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06003725 currently recruiting?
Yes, NCT06003725 is actively recruiting participants. Contact the research team at brittany.bryant@ucsf.edu for enrollment information.
Where is the NCT06003725 trial being conducted?
This trial is being conducted at San Francisco, United States, Charleston, United States.
Who is sponsoring the NCT06003725 clinical trial?
NCT06003725 is sponsored by University of California, San Francisco. The principal investigator is Brittany Bryant, DSW at University of California, San Francisco. The trial plans to enroll 55 participants.